Healthcare Analytics Decoded: Analyzing the Impact of COVID-19

 

On this episode of Healthcare Analytics Decoded, a Quantros podcast, Quantros’ Lindsey Klein was joined by SVP and Chief System of Care Integration Officer for Navicent Health Dr. Reg Gilbreath.

Dr. Gilbreath and Klein engaged in a wide-ranging discussion on the impacts of the COVID-19 pandemic on the healthcare system, our collective march toward a new normal, and more.

Gilbreath said he’s been impressed with how the healthcare industry has been able to adapt to managing COVID-19 and the pandemic as quickly as it has.

“For the most part, the healthcare industry in America has risen to the challenge, I think,” he said.

From a data perspective, Gilbreath said it’s difficult to tell how long it may take reporting and analysis to return to a pre-pandemic normal, if it ever does.

“It kind of depends on the current pandemic. Is it a three-month window we’re looking at? Is it business as usual in the summer? … Or is it 24 months just to handle this current pandemic?,” he said.

Gilbreath said there’s even a potential for COVID-19 to reappear annually, similar to the seasonal flu. In short, there’s currently too much we don’t know.

Though projections for the true onset of a “new normal” vary, Gilbreath said there has to be some movement toward normalcy in healthcare sooner rather than later.

“At some point, we’ve got to incorporate normalcy, if you will,” he said. “There are a lot of people with a backlog of elective surgeries.”

In particular, Gilbreath said “survival-based” procedures, like those concerning cancer, will be prioritized, but symptom-based issues causing severe disruptions also need to begin resuming when possible.

Klein and Gilbreath also dove into which innovations could be holdovers from the pandemic era, such as telemedicine and online scheduling, how funding could increase for underserved demographics as a result of COVID-19 risk, and more.

For more information on the current and future impact of COVID-19, visit Quantros.com

Follow us on social media for the latest updates in B2B!

Image

Latest

AMAG Technology
AMAG Technology: Control, Reliability, and Customer-First Supply Chain Excellence
April 2, 2025

At AMAG Technology, being customer-obsessed goes beyond a mindset—it’s built into every part of the operation. One of the company’s greatest strengths lies in its ability to manufacture its own products, offering a level of supply chain control that few competitors can match. Allan Price, Head of Global Supply Chain at AMAG, emphasizes how this…

Read More
visitor management solution
Reinventing Visitor Management Solution with Symmetry GUEST
April 2, 2025

In an age where speed and security are paramount, the traditional paper logbook is becoming a relic of the past. AMAG Technology’s Symmetry Guest system offers a modern, digital solution that redefines the way organizations welcome and manage visitors. Gone are the days of long lines and confusion at the front desk—Symmetry Guest empowers hosts…

Read More
AMAG
Driven by Customers, Defined by Innovation: Inside AMAG’s Customer-Obsessed Approach
April 2, 2025

AMAG Technology continues to strengthen its customer-obsessed culture by actively listening to both internal and external voices. As shared by Kyle Gordon, Executive Vice President of Global Sales, Marketing, & Commercial Excellence, the company is focused on improving processes, responding with speed, and driving innovation—while honoring its legacy and delivering unique value within the industry.

Read More
biotech
Biotech Moves Smarter: IDDI Powers Data-Driven Drug Innovation
April 2, 2025

As biotech innovation accelerates, small and mid-size pharmaceutical companies are becoming key players in bringing new treatments to market. Yet many of these organizations face steep challenges when navigating clinical trial design, regulatory approval, and data integrity. According to a McKinsey Global Institute report, industries like biotech could help generate up to $50 trillion…

Read More